Course Information

26th Annual UCLA Brain Attack! '22: Symposium on State-of-the-Art Stroke Management

Live Virtual Learning

May 14, 2022

Download: [ PDF ]

General Information

Offered entirely remotely!

The UCLA Brain Attack! '22 Virtual Symposium will be available through a live virtual meeting web platform.

  • Registrants will be able to participate live in the UCLA Brain Attack! '22 Virtual Symposium.
  • Registrants will receive a virtual meeting link and password to access the virtual conference.
  • Registrants will be provided the opportunity to review recorded sessions up to 3 weeks following the conference.

Target Audience

Neurologists, neurosurgeons, interventional neuroradiologists, emergency physicians, family practice physicians, internists, and other health care professionals who want to enhance their knowledge of the management of patients with cerebrovascular diseases.

Enrollment

To enroll click here.

Registration Deadline: Registration will close at 11:59 PM on Friday, May 13th.

Enrollment on the day of the course: Registration will only be accepted between 7:00 AM - 10:00 AM (Pacific Standard Time). Please call our day-of registration representative at (512) 270-8113 or email us at UCLACME@mednet.ucla.edu to enroll.

Course Fee

  • $100

Refunds

Cancellations must be received in writing by Friday, April 15, 2022 and will be subject to a $25 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. You may email your refund request to UCLACME@mednet.ucla.edu.

Jamil A. Aboulhosn, MD
Director, Ahmanson / UCLA Adult Congenital Heart Center
Associate Professor of Clinical Medicine*
Divisions of Cardiology and Pediatric Cardiology

Noel G. Boyle, MD, PhD
Professor of Clinical Medicine*
UCLA Cardiac Arrhythmia Center

Geoffrey P. Colby, MD, PhD
Director, Division of Cerebrovascular Neurosurgery
Department of Neurosurgery

Steven C. Cramer, MD
Professor of Neurology*
Medical Director of Research, California Rehabilitation Institute
Director, Neurologic Rehabilitation and Research Program

Jason D. Hinman, MD, PhD
Assistant Professor of Neurology*

Reza Jahan, MD
Professor and Director of Academic Affairs*
Division of Interventional Neuroradiology

David S. Liebeskind, MD
Professor of Neurology*
Director, Neurovascular Imaging Research Core
Director, UCLA Comprehensive Stroke Center

Katherine Mun, MD
Clinical Instructor and Vascular Neurology
Research Fellow of Neurology*

May Nour, MD, PhD
Medical Director, UCLA Mobile Stroke Rescue Program
Assistant Professor of Neurology and Radiology*
UCLA Comprehensive Stroke Center
Division of Interventional Neuroradiology

Neal M. Rao, MD
Associate Professor of Neurology*
Director, Olive View-UCLA Medical Center Stroke Program

Jeffrey L. Saver, MD
Director, Stroke Neurology
Department of Neurology

Sidney Starkman, MD
Director, Emergency Neurology
Departments of Emergency Medicine and Neurology

Viktor Szeder, MD, PhD, MSc
Associate Clinical Professor of Radiology and Neurosurgery*
Co-Director, Fellowship Training Program
Division of Interventional Neuroradiology

Satoshi Tateshima, MD, PhD
Professor of Radiology*
Division of Interventional Neuroradiology

Paul M. Vespa, MD
Assistant Dean of Critical Care Medicine (Research)
Gary L. Brinderson Family Chair in Neurocritical Care
Professor of Neurology and Neurosurgery*

Bryan Y. Yoo, MD
Assistant Clinical Professor of Radiology*
Division of Neuroradiology
 

*David Geffen School of Medicine at UCLA

Saturday, May 14, 2022

7:45 am (PST) Welcome and Orientation
Jeffrey L. Saver, MD and Sidney Starkman, MD
8:00 am Occult Atrial Fibrillation, Atrial Cardiopathy and Stroke: Diagnostic Advances
Noel G. Boyle, MD, PhD
8:30 am Closing Holes and Pouches: Endovascular Treatment for PFO and Left Atrial Occlusion
Jamil A. Aboulhosn, MD
9:00 am Lipids, Cerebral Atherosclerosis and Stroke
David S. Liebeskind, MD
9:30 am Break
9:45 am Mobile Stroke Units: From Trials to Practice
May Nour, MD, PhD
10:15 am Neuroimaging of Ischemic Stroke and Intracerebral Hemorrhage
Bryan Y. Yoo, MD
10:45 am Intravenous Thrombolysis: New Agents and New Strategies
Neal M. Rao, MD
11:15 am Endovascular Thrombectomy: The Next Frontiers
Reza Jahan, MD
11:45 am Lunch
12:30 pm Critical Care for Ischemic and Hemorrhagic Stroke
Paul M. Vespa, MD
1:00 PM Advances in Brain Aneurysm Treatment
Geoffrey P. Colby, MD, PhD
1:30 pm Endovascular Treatment of Arteriovenous Malformations and Arteriovenous Fistulas
Viktor Szeder, MD, PhD, MSc
2:00 pm Robotic Endovascular Treatment for Cerebrovascular Disease
Satoshi Tateshima, MD, PhD
2:30 pm Break
2:45 pm Cerebrovascular Disease Associated with the Coronavirus
Jason D. Hinman, MD, PhD
3:15 pm Preventing Dementia by Treating Cerebrovascular Disease
Katherine Mun, MD
3:45 pm Predictors of Response to Stroke Recovery Therapies
Steven C. Cramer, MD
4:15 pm Here There be Dragons: Prevention, Diagnosis, and Treatment Beyond the Guidelines
Jeffrey L. Saver, MD
4:45 pm Adjourn

At the conclusion of this program participants should be able to:

  • Utilize recent advances in the treatment of atrial fibrillation
  • Apply recent developments in endovascular and intravenous treatment of acute ischemic stroke
  • Employ recent developments in management of intracerebral hemorrhage and intracranial aneurysms
  • Describe therapies for stroke rehabilitation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Ischemic Stroke:
Medical and Procedural Emergency Treatment, Prevention, and Rehabilitation

The UCLA Comprehensive Stroke Center presents its annual Brain Attack symposium to review the practical, clinical aspects of stroke prevention, diagnosis, and treatment. The course will cover stroke risk factors, diagnostic testing, and medical and interventional therapy.

Intravenous thrombolysis and neuroendovascular thrombectomy are highly effective techniques for treatment of acute ischemic stroke. The results of recent studies indicate that these reperfusion therapies are beneficial up to 4.5-6 hours after symptom onset in most patients, and up to 24 hours in imagingselected patients. A highly coordinated team approach is required to provide these treatments safely and effectively.

Neuroimaging techniques are playing an increasingly important role in the evaluation of stroke patients. Faculty will provide an in-depth discussion of innovative MR and CT techniques.

The UCLA Comprehensive Stroke Center

The UCLA Comprehensive Stroke Center maintains a comprehensive treatment and clinical trials program for patients with cerebrovascular disorders. The UCLA Comprehensive Stroke Center – the first Joint Commission certified stroke center in Los Angeles County, provides multidisciplinary care for patients with stroke and kindred disorders including prevention, acute brain rescue, interventional neuroradiological and surgical therapy, and multimodal rehabilitation. The UCLA Comprehensive Stroke Center’s treatment approach includes emergency physicians, stroke neurologists, vascular neurosurgeons, vascular surgeons, diagnostic and interventional neuroradiologists, and rehabilitation physicians.

Cerebral Aneurysms, Subarachnoid Hemorrhage, and Intracerebral Hemorrhage

Tremendous strides have been made in the management of complex vascular lesions of the brain and spinal cord. This symposium will provide a review of the basic principles of clinical and interventional management of cerebral aneurysms, subarachnoid hemorrhage, and intracerebral hemorrhage. Developments in microsurgical and endovascular techniques will be discussed.

The UCLA Cerebrovascular Program

The UCLA Cerebrovascular Program has developed management protocols for the diagnosis and treatment of cerebrovascular disorders which incorporate diagnostic and interventional neuroradiology, microneurosurgery, stereotactic radiosurgery, neuroanesthesiology, neurocritical care, and intensive medical management. The members of the UCLA Cerebrovascular Program have worked cooperatively for three decades with all of the management components available on-site at UCLA, allowing for efficient coordination of the various techniques.